MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 44 filers reported holding MEDGENICS INC in Q1 2015. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $179,000 | -3.2% | 33,273 | 0.0% | 0.17% | -2.3% |
| Q2 2016 | $185,000 | +23.3% | 33,273 | -2.5% | 0.17% | +26.3% |
| Q1 2016 | $150,000 | -26.8% | 34,134 | 0.0% | 0.14% | -14.4% |
| Q4 2015 | $205,000 | -23.2% | 34,134 | 0.0% | 0.16% | -25.2% |
| Q3 2015 | $267,000 | +27.8% | 34,134 | 0.0% | 0.21% | +50.7% |
| Q2 2015 | $209,000 | -24.0% | 34,134 | 0.0% | 0.14% | -30.7% |
| Q1 2015 | $275,000 | +46.3% | 34,134 | -8.1% | 0.20% | +103.0% |
| Q4 2014 | $188,000 | +80.8% | 37,134 | +84.4% | 0.10% | +80.4% |
| Q3 2014 | $104,000 | -33.3% | 20,134 | 0.0% | 0.06% | -28.2% |
| Q2 2014 | $156,000 | +10.6% | 20,134 | 0.0% | 0.08% | +4.0% |
| Q1 2014 | $141,000 | +11.0% | 20,134 | -5.4% | 0.08% | +8.7% |
| Q4 2013 | $127,000 | -32.4% | 21,282 | -11.8% | 0.07% | -35.5% |
| Q3 2013 | $188,000 | +64.9% | 24,128 | -19.5% | 0.11% | +67.2% |
| Q2 2013 | $114,000 | – | 29,978 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,390,000 | $8,368,000 | 3.50% |
| Broadfin Capital, LLC | 3,045,306 | $18,333,000 | 1.13% |
| Belmont Global Advisors, Inc. | 65,000 | $391,000 | 0.51% |
| QVT Financial LP | 867,608 | $5,223,000 | 0.29% |
| CARL DOMINO INC | 34,134 | $205,000 | 0.16% |
| Spark Investment Management LLC | 77,400 | $465,000 | 0.06% |
| WHITE PINE CAPITAL LLC | 20,000 | $120,000 | 0.05% |
| Alambic Investment Management, L.P. | 11,220 | $68,000 | 0.04% |
| Baker Brothers Advisors | 765,000 | $4,605,000 | 0.04% |
| HYMAN CHARLES D | 15,143 | $91,000 | 0.02% |